Clinical Trial Update: Oral Nemonoxacin in Treating Elderly Patients With CAP [Phase 4]

View source ↗

Summary

Phase 4 trial update on oral nemonoxacin for treating community-acquired pneumonia in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Nemonoxacin (Nemonoxacin)

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Community-acquired Pneumonia | Phase 4 | Status: COMPLETED